Product Information
NORG-ETHIN ESTRA 0.25-0.035 MG is a generic product labeled by Glenmark Pharmaceuticals Inc., USA, priced at $0.1148 per EA under NDC 68462030929. Its NADAC has been published 671 times since Nov 28, 2013.
FDA first approved this application on Apr 5, 2012. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Manufacturer
Glenmark Pharmaceuticals Inc., USANDC
68462030929
Classification
Generic
Dosage Form
KIT
Effective Date
9/23/2026
Approval Type
Generic (ANDA)
FDA Application
ANDA200538FDA Approved
4/5/2012
TE Code
AB
On Market Since
4/6/2012
Price Statistics
The NADAC for NORG-ETHIN ESTRA 0.25-0.035 MG has been published 671 times since Nov 28, 2013, and over the history we have for it it has declined 67.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1148 per EA |
|---|---|
| All-time high | $0.3850 (Mar 12, 2014) |
| All-time low | $0.1011 (Nov 20, 2024) |
| 52-week high | $0.1275 |
| 52-week low | $0.1148 |
| Median price | $0.2269 |
| Average price | $0.2321 |
| Largest weekly change | -21.9% (Nov 20, 2024) |
| Weeks tracked | 671 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Glenmark Pharmaceuticals Inc., USA manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Norgestimate and Ethinyl Estradiol market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of NORG-ETHIN ESTRA 0.25-0.035 MG?
The current National Average Drug Acquisition Cost (NADAC) for NORG-ETHIN ESTRA 0.25-0.035 MG, manufactured by Glenmark Pharmaceuticals Inc., USA, is $0.1148 per EA (NDC 68462030929), effective Sep 30, 2026.
How has the price of NORG-ETHIN ESTRA 0.25-0.035 MG changed over time?
Over the history we have for it, the NADAC for NORG-ETHIN ESTRA 0.25-0.035 MG has declined 67.9%. It has been tracked across 671 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for NORG-ETHIN ESTRA 0.25-0.035 MG?
Since Nov 28, 2013, the NADAC for NORG-ETHIN ESTRA 0.25-0.035 MG has ranged from a low of $0.1011 (Nov 20, 2024) to a high of $0.3850 (Mar 12, 2014), with a median of $0.2269 per EA.
Are there cheaper alternatives to NORG-ETHIN ESTRA 0.25-0.035 MG?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, TRI-VYLIBRA LO TABLET, is $0.1080 per EA — about 6% below NORG-ETHIN ESTRA 0.25-0.035 MG.
Who manufactures NORG-ETHIN ESTRA 0.25-0.035 MG?
NORG-ETHIN ESTRA 0.25-0.035 MG (NDC 68462030929) is labeled by Glenmark Pharmaceuticals Inc., USA, and CMS classifies it as a generic product.